Galderma (U.K.) Limited has informed the MHRA that the Patient Information Leaflet (PIL) packaged in some batches of Epiduo 0.1% / 2.5% gel contain outdated safety information regarding pregnancy.
MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-galderma-uk-limited-epiduo-0-dot-1-percent-slash-2-dot-5-percent-gel-45-g-el-22-a-slash-52
|
This is a caution in use only we are not accepting stock returns - if any defective stock is found it should be returned directly to the manufacturer.
Further information
For more information, medical information queries or replacement PIL enquiries, please contact: medinfo.uk@galderma.com
For stock control queries, please contact: sales.uk@galderma.com
Recipients of this Medicines Notification should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.